Sentinel lymph node mapping is a diagnostic procedure used to determine the presence and extent of cancer spread in the lymphatic system. It involves injecting a radioactive substance, blue dye, or both near the tumor site, which then travels to the sentinel lymph node(s), the first lymph node(s) from which cancer cells would likely spread. The sentinel node(s) are then removed and examined for cancer cells, helping guide further treatment decisions.